Overview
The development of CRISPR/Cas9 gene editing technology opened a new frontier in biomedical research. Adapted to take advantage of natural cellular repair processes, CRISPR/Cas9 permits the editing of targeted genes with unprecedented simplicity and flexibility. The incredible potential of this technology for treating human genetic disease inspired a group of life science veterans to create Intellia Therapeutics.